{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:38:03Z","timestamp":1787755083714,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBJS Rev"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Guidelines recommending various nonoperative treatments for patients with knee osteoarthritis remain inconsistent. Much of this controversy relates to what constitutes a clinically important effect. The purposes of the present study were to compare treatment effect sizes from recent meta-analyses evaluating pharmacological or medical device interventions for the treatment of knee osteoarthritis and to further assess the clinical impact that the intra-articular placebo effect may have on intra-articular injection therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A search of PubMed, MEDLINE, and Embase from the inception date of each database through May 30, 2017 was conducted for all articles involving meta-analyses of pharmacological or medical device knee osteoarthritis treatments compared with controls. Two reviewers independently screened articles for eligibility and extracted data for analysis. We present effect estimates on a standardized mean difference (SMD) scale and compare them all against a threshold for clinical importance of 0.50 standard deviation (SD) unit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Ten meta-analyses (sample size range, 110 to 39,814) providing a total of 19 different effect sizes for pain were included in this review. SMD estimates ranged from 0.08 to 0.79 for various electrical modalities, orthotic devices, topical and oral nonsteroidal anti-inflammatory drugs (NSAIDs), dietary supplements, and intra-articular injection therapies. Seventeen treatments demonstrated significant improvements in terms of pain when patients who had received treatment were compared with controls. After accounting for the intra-articular placebo effect, the greatest effect estimates were those of intra-articular platelet-rich plasma and high molecular weight hyaluronic acid. When these were judged according to our threshold for clinical importance, high molecular weight intra-articular hyaluronic acid was found to have the most precise effect estimate that surpassed this threshold. Platelet-rich plasma was found to provide the greatest point estimate of the treatment effect, but the precision around this estimate had the largest amount of uncertainty across all treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>While many nonoperative treatments demonstrated significant improvements in pain, we found the greatest effect estimates for intra-articular treatments. While platelet-rich plasma provided the greatest point estimate of the treatment effect, variability among studies suggests that future research into optimal formulations is required. The strongest current evidence supports clinically important and significant treatment effects with intra-articular hyaluronic acid formulations between 1,500 and &gt;6,000 kDa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level I<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.rvw.17.00167","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T18:48:52Z","timestamp":1531766932000},"page":"e5-e5","source":"Crossref","is-referenced-by-count":63,"title":["Nonoperative Treatments for Knee Osteoarthritis: An Evaluation of Treatment Characteristics and the Intra-Articular Placebo Effect"],"prefix":"10.2106","volume":"6","author":[{"given":"Christopher","family":"Vannabouathong","sequence":"first","affiliation":[{"name":"OrthoEvidence, Inc., Burlington, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Center for Evidence-Based Orthopaedics (M.B.), and Department of Surgery, Faculty of Health Sciences (V.K.), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asheesh","family":"Bedi","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickas","family":"Khanna","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Center for Evidence-Based Orthopaedics (M.B.), and Department of Surgery, Faculty of Health Sciences (V.K.), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yung","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Dr. L.H. Hiranandani Hospital, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-8095","authenticated-orcid":false,"given":"Moin","family":"Khan","sequence":"additional","affiliation":[{"name":"OrthoEvidence, Inc., Burlington, Ontario, Canada"},{"name":"University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,7]]},"reference":[{"issue":"20","key":"r2-20230908","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2106\/00004623-201310160-00010","article-title":"American Academy of Orthopaedic Surgeons. The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition","volume":"95","author":"Jevsevar","year":"2013","journal-title":"J Bone Joint Surg Am."},{"issue":"3","key":"r3-20230908","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"r4-20230908","first-page":"49","article-title":"Osteoarthritis: diagnosis and treatment","volume":"85","author":"Sinusas","year":"2012","journal-title":"Am Fam Physician"},{"issue":"1","key":"r5-20230908","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M14-1231","article-title":"Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis","volume":"162","author":"Bannuru","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"r6-20230908","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M15-0623","article-title":"Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials","volume":"163","author":"Bannuru","year":"2015","journal-title":"Ann Intern Med"},{"key":"r7-20230908","doi-asserted-by":"crossref","first-page":"16827","DOI":"10.1038\/srep16827","article-title":"Effectiveness and safety of glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee","volume":"5","author":"Zeng","year":"2015","journal-title":"Sci Rep"},{"issue":"5","key":"r8-20230908","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00167-015-3784-4","article-title":"Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee","volume":"24","author":"Kanchanatawan","year":"2016","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"2","key":"r9-20230908","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/AJP.0000000000000233","article-title":"Transcutaneous electrical nerve stimulation in patients with knee osteoarthritis: evidence from randomized-controlled trials","volume":"32","author":"Chen","year":"2016","journal-title":"Clin J Pain"},{"issue":"4","key":"r10-20230908","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/acr.22472","article-title":"Valgus bracing for knee osteoarthritis: a meta-analysis of randomized trials","volume":"67","author":"Moyer","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"r11-20230908","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.joca.2013.06.015","article-title":"Efficacy of low frequency pulsed subsensory threshold electrical stimulation vs placebo on pain and physical function in people with knee osteoarthritis: systematic review with meta-analysis","volume":"21","author":"Negm","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"r12-20230908","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2013.243229","article-title":"Lateral wedge insoles as a conservative treatment for pain in patients with medial knee osteoarthritis: a meta-analysis","volume":"310","author":"Parkes","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"r13-20230908","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.joca.2014.06.028","article-title":"Effectiveness of continuous and pulsed ultrasound for the management of knee osteoarthritis: a systematic review and network meta-analysis","volume":"22","author":"Zeng","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"r14-20230908","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2015.04.013","article-title":"Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid","volume":"45","author":"Altman","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"r15-20230908","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.semarthrit.2013.11.012","article-title":"A systematic review of recommendations and guidelines for the management of osteoarthritis: the chronic osteoarthritis management initiative of the U.S. Bone and Joint Initiative","volume":"43","author":"Nelson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"r16-20230908","doi-asserted-by":"crossref","first-page":"32790","DOI":"10.1038\/srep32790","article-title":"Intra-articular hyaluronic acid in treating knee osteoarthritis: a PRISMA-compliant systematic review of overlapping meta-analysis","volume":"6","author":"Xing","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"r17-20230908","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"issue":"12","key":"r18-20230908","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/ard.2008.097006","article-title":"The art of medicine in treating osteoarthritis: I will please","volume":"67","author":"Bijlsma","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"r19-20230908","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1533-2500.2007.00104.x","article-title":"Placebo theory and its implications for research and clinical practice: a review of the recent literature","volume":"7","author":"Koshi","year":"2007","journal-title":"Pain Pract"},{"issue":"11","key":"r20-20230908","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1177\/0363546516680607","article-title":"The therapeutic effect of intra-articular normal saline injections for knee osteoarthritis: a meta-analysis of evidence level 1 studies","volume":"45","author":"Saltzman","year":"2017","journal-title":"Am J Sports Med"},{"issue":"7","key":"r21-20230908","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jclp.20129","article-title":"The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials","volume":"61","author":"Wampold","year":"2005","journal-title":"J Clin Psychol"},{"issue":"12","key":"r22-20230908","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/ard.2008.092015","article-title":"The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials","volume":"67","author":"Zhang","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"r24-20230908","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"r27-20230908","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"3","key":"r28-20230908","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-157-3-201208070-00473","article-title":"Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis","volume":"157","author":"Rutjes","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"r29-20230908","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"r30-20230908","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.arthro.2016.09.024","article-title":"Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials","volume":"33","author":"Dai","year":"2017","journal-title":"Arthroscopy"},{"issue":"23","key":"r31-20230908","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.290.23.3115","article-title":"Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis","volume":"290","author":"Lo","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"r32-20230908","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1177\/0363546515609599","article-title":"Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee","volume":"44","author":"Altman","year":"2016","journal-title":"Am J Sports Med"},{"issue":"9","key":"r33-20230908","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2016-210860","article-title":"Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)","volume":"76","author":"Reginster","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"r34-20230908","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/2046-4053-3-110","article-title":"A Microsoft-Excel-based tool for running and critically appraising network meta-analyses\u2014an overview and application of NetMetaXL","volume":"3","author":"Brown","year":"2014","journal-title":"Syst Rev."},{"issue":"12","key":"r35-20230908","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to use an article reporting a multiple treatment comparison meta-analysis","volume":"308","author":"Mills","year":"2012","journal-title":"JAMA"},{"key":"r36-20230908","doi-asserted-by":"crossref","first-page":"f2914","DOI":"10.1136\/bmj.f2914","article-title":"Demystifying trial networks and network meta-analysis","volume":"346","author":"Mills","year":"2013","journal-title":"BMJ"},{"issue":"12","key":"r37-20230908","doi-asserted-by":"crossref","first-page":"739","DOI":"10.5435\/JAAOS-22-08-469","article-title":"Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment","volume":"21","author":"Hsu","year":"2013","journal-title":"J Am Acad Orthop Surg"},{"issue":"7","key":"r38-20230908","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s11999-015-4207-z","article-title":"Cochrane in CORR (\u00ae): platelet-rich therapies for musculoskeletal soft tissue injuries","volume":"473","author":"Khan","year":"2015","journal-title":"Clin Orthop Relat Res."}],"container-title":["JBJS Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01874474-201807000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:37:14Z","timestamp":1787751434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01874474-201807000-00002"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.rvw.17.00167","relation":{},"ISSN":["2329-9185"],"issn-type":[{"value":"2329-9185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}